Skip to main
BSX

Boston Scientific (BSX) Stock Forecast & Price Target

Boston Scientific (BSX) Analyst Ratings

Based on 21 analyst ratings
Buy
Strong Buy 48%
Buy 52%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Boston Scientific is expected to face some challenges, but overall has a strong track record and outlook due to their focus on cutting-edge technology and market expansion, as well as their commitment to ethical and responsible business practices. Their financials show positive trends, with a 2022 revenue growth rate of 9.1% and a gross profit margin of 72.6%. Their diverse product offerings and global presence also make them well-positioned for future growth.

Bears say

Boston Scientific is facing challenges in its Urology and CRM businesses and these challenges, along with increased R&D expenses, have caused a decrease in operating margin. Additionally, the company's guidance for 2026 has been lowered, with slower growth expected in important products such as FARAPULSE and WATCHMAN. These factors lead to a negative outlook for the stock's performance in the near future.

Boston Scientific (BSX) has been analyzed by 21 analysts, with a consensus rating of Buy. 48% of analysts recommend a Strong Buy, 52% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Boston Scientific and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Boston Scientific (BSX) Forecast

Analysts have given Boston Scientific (BSX) a Buy based on their latest research and market trends.

According to 21 analysts, Boston Scientific (BSX) has a Buy consensus rating as of May 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $91.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $91.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Boston Scientific (BSX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.